In summary, mechanisms of resistance to venetoclax monotherapy are varied, from mutation of the drug binding pocket of BCL2 itself, to amplification of parallel anti apoptotic signaling pathways, changes in energy metabolism, and epigenetic alterations <a href=https://propecia.mom>buy generic propecia</a>
Статья
Обсуждение